This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
September 15-18, 2025
Hynes Convention CenterBoston, USA
Book Now & Save $700 by July 11
Menu
Book Now
Key Sessions
Niklas Engler
PLENARY KEYNOTE: CMC Development - A Key Differentiator for Biotech
F. Hoffmann-La Roche
James Warren, Ph.D.
PLENARY KEYNOTE: Strategic Considerations for the BLA-Enabling CMC Development of AAV Gene Therapy Programs
Ultragenyx Pharmaceutical Inc.
Amy Shaw
Scale-Out Versus Scale-Up Strategies for Maximizing Cellular Therapies
Takeda, USA
Kelvin Lee
KEYNOTE: The Future of Biopharmaceutical Manufacturing: Innovation and Collaboration
NIIMBL
keyboard_arrow_right

Wednesday 17th September - Main Conference Day Two - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
search
Wednesday 17th September - Main Conference Day Two - ET (Eastern Time, GMT-05:00)
search
Showing 1 of 1 Streams
11:25am - 11:30am
Chairperson Remarks: Cell Culture & Upstream Processing
11:30am - 12:00pm
Next-Gen Upstream Lab: Flexible and Scalable AI Deployment with MLOps
  • Shu Yang - Senior Scientist, Pfizer
  • Edwin Shen - Principal Scientist, Pfizer
12:00pm - 12:30pm
Error Reduction Using Small-Scale Models and Scale-Up Insights
  • Prasad Pathange - Senior Manager, Bayer U.S.
12:30pm - 1:00pm
Sponsored Presentation: Emerging Tools for Real-Time Process Monitoring

• Recent advancements in Raman spectroscopy, near-infrared (NIR) spectroscopy, and IR spectroscopy

• Case studies on implementing high-throughput PAT for upstream process development

• Challenges and opportunities in scaling PAT for GMP bioreactors and downstream processes.

Showing 1 of 1 Streams
2:10pm - 2:15pm
Chairperson Remarks: Cell Culture & Upstream Processing
2:15pm - 2:45pm
Leveraging Capacitance in Perfusion Bioreactors in the Generation2 Ambr(R) 250 High Throughput
  • Lorraine Peters - Associate Scientist, AstraZeneca
2:45pm - 3:15pm
Scale-Down Model Qualification and Process Characterization Utilizing the Second-Generation Ambr® 250 High Throughput Mini Bioreactor System
  • Coral Fung Shek - Process Development Associate Scientist, Amgen
3:15pm - 3:45pm
Optimising poloxamer 188 for CHO and HEK suspension cells for reduced batch-to-batch variation
  • Kritika Bajaj - Lead Research Scientist, Croda
Showing 1 of 1 Streams
4:30pm - 5:00pm
Identifying upstream levers to improve monomer purity in antibody production
  • Yingnan (Michael) Si - Scientist, Sanofi
5:00pm - 5:30pm
Fireside Chat: How do we go to the next level for Cell Culture and Upstream Development?
  • Charles Sardonini, PhD - Consultant to the Biotechnology Industry, Sardonini Consulting, LLC
Tuesday 16th September - Main Conference Day One
NextThursday 18th September - Main Conference Day Three
Filter
Streams
Clear
Choose Day